Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 Symptoms
NCT05484700 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 305
Last updated 2022-08-05
Summary
We investigated the association between immune system responsibilities in Long COVID patients and Full recovery patients.
Conditions
- Long COVID-19
Sponsors & Collaborators
-
Mahidol University
lead OTHER
Principal Investigators
-
Korapat Mayurasakorn, MD. · Doctor in Family Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-12-30
- Primary Completion
- 2022-07-25
- Completion
- 2022-12-29
Countries
- Thailand
Study Locations
More Related Trials
-
Investigating Development of Autoimmunity in Post-Acute COVID-19 Syndrome (PACS)
NCT05459506 ·Status: UNKNOWN
-
Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?
NCT04469634 ·Status: COMPLETED ·Phase: NA
-
Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection
NCT05242159 ·Status: UNKNOWN
-
COVID-19 IgG Formation in Physicians at ALGH and Their Household Members
NCT04540484 ·Status: COMPLETED
-
Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre
NCT04446338 ·Status: UNKNOWN
-
Autoimmunity Contributes to the Severe Progression of COVID-19
NCT04967781 ·Status: COMPLETED
-
Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 Variants
NCT05858502 ·Status: RECRUITING ·Phase: NA
-
Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive
NCT04605952 ·Status: COMPLETED
-
COVID-19 Antibodies Among Healthcare Workers
NCT04425889 ·Status: COMPLETED
-
Characterization of the Immunometabolic Signature in Long COVID-19.
NCT05758480 ·Status: COMPLETED ·Phase: NA
-
COVID-19 IgG Antibodies in the Serum of Recovered Patients
NCT04470414 ·Status: UNKNOWN
-
Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients
NCT04410471 ·Status: UNKNOWN
-
Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
NCT04800731 ·Status: COMPLETED
-
Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)
NCT04453280 ·Status: COMPLETED
-
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
NCT06762002 ·Status: RECRUITING
-
Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients
NCT04817553 ·Status: COMPLETED
-
Seroconversion in COVID-19 Recovered Population
NCT04558385 ·Status: COMPLETED
-
Gene Polymorphism of IL17 and IL 23
NCT04948515 ·Status: COMPLETED
-
SARS-CoV-2 IgG and IgM Serologic Assays
NCT04562246 ·Status: COMPLETED
-
Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19
NCT04367714 ·Status: UNKNOWN
-
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
NCT05965843 ·Status: UNKNOWN
-
COVID-19 Immune Repertoire Sequencing
NCT04368143 ·Status: COMPLETED
-
Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
NCT00001257 ·Status: TERMINATED
-
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays
NCT04562285 ·Status: COMPLETED
-
Immunoadsorption vs. Sham Treatment in Post COVID-19 Patients With Chronic Fatigue Syndrome
NCT05954325 ·Status: COMPLETED ·Phase: NA